Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Medmonk logo — Revolutionizing Patient Access to Vital Therapies

Medmonk

Revolutionizing Patient Access to Vital Therapies

Founded 2012 14 employees Seed Total: $10.00M Biotechnology, Health Care +1

General Information

Company Name Medmonk
Founded Year 2012
Employees 14
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Medmonk. To contact Medmonk, visit medmonk.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Medmonk compare?

A PDF of Medmonk and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Medmonk soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Medmonk

Medmonk, founded in 2012, is a biotechnology and pharmaceutical startup with a clear mission to revolutionize patient access to vital therapies. The company's dedication to transforming the way patients access medications for rare conditions is evident in their approach, which is grounded in two pivotal principles: 'Speed to Therapy' and providing 'Customization for Your Brand'. The startup acknowledges the need for agile, adaptive solutions for pharmaceutical manufacturers facing the unique challenges of rare diseases and niche brands. Medmonk expertly manages brand support for these rare conditions, ensuring coverage through pharmacy and medical benefits. What sets Medmonk apart is its in-depth expertise in rare disease brand management, robust network of specialty pharmacies, and seamless integration with 98% of specialty pharmacies, buy & bill facilities, and infusion centers nationwide. The last investment in Medmonk was a INR10.00M Seed Round investment on 10 October 2016 by Sudip Bandopadhyay, Rahul Singh, and Mohit Goel. In the complex terrain of today's healthcare, Medmonk plays a pivotal role in maintaining patient health trajectories, emphasizing sustained health and well-being by ensuring timely treatment. The company's platform streamlines the processes of patient enrollment in hub services, co-pay assistance, and reimbursement support, aligning with medical and pharmacy benefits. Medmonk's dedication to expediting treatment delivery aligns with its philosophy that timely access to medications is a trifecta of success for the patient, healthcare provider, and pharmaceutical brand.

Business keywords: pharmaceutical brand management, patient access, rare disease treatment, specialty pharmacies, healthcare integration, co-pay assistance, reimbursement support, patient support services, PAP service

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round INR10.00M 3
Sudip Bandopadhyay, Rahul Singh +1
10 Oct 2016
Seed Round Undisclosed 3
Y Combinator Rock Health Capital
Y Combinator, Rock Health Capital +1
01 Jan 2012

Medmonk Alternatives & Competitors

View All Alternatives
Medmonk vs
Vivo Health Pharmacy
Vivo Health Pharmacy United States

We're here for you. Every step. Every question. Every day.

91 employees
Health Care, Pharmaceutical
Medmonk vs
BioPlus Specialty Pharmacy
BioPlus Specialty Pharmacy United States

BioPlus Specialty Pharmacy ranks #1 by both patients and providers.

525 employees
Health Care, Pharmaceutical
Medmonk vs
Diplomat
Diplomat United States

We strive to help every patient realize longer, fuller lives.

682 employees
Health Care, Pharmaceutical
View all alternatives

FAQ About Medmonk

Revolutionizing Patient Access to Vital Therapies
Medmonk was founded in 2012.
Medmonk operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceutical brand management, patient access, rare disease treatment and specialty pharmacies.
Medmonk has approximately 14 employees.
Medmonk has completed 2 funding rounds, raising a total of $10.00M. The latest funding stage is Seed.
Top alternatives and competitors to Medmonk include Vivo Health Pharmacy, BioPlus Specialty Pharmacy, Diplomat, Santa Barbara Specialty Pharmacy, Fera Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Medmonk and Vivo Health Pharmacy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Medmonk, https://bouncewatch.com/company/medmonk, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes